Quetiapine for the Treatment of Insomnia in Alzheimer's Disease
Status:
Unknown status
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The primary hypothesis is that quetiapine will improve sleep in persons with Alzheimer's
Disease (AD), with higher doses producing greater total sleep time and sleep efficiency.
Phase:
N/A
Details
Lead Sponsor:
University of Vermont
Collaborators:
AstraZeneca National Center for Research Resources (NCRR)